KRAS and cancer: Notwithstanding cancers with other mutations and other myeloid cells like neutrophils and mast cells that might also fuel tumors with IL-1β, we define here a non-oncogene addiction of KRAS and IL-1β, in tandem with their partners in crime VCAN and IKKβ.